View Item 

Show simple item record

PREVENTION OF INTRAVENTRICULAR HAEMORRHAGE IN PRETERM INFANTS BY PHENOBARBITONE : A Controlled Trial
dc.contributor.authorDonn, Steven M.en_US
dc.contributor.authorRoloff, Dietrich W.en_US
dc.contributor.authorGoldstein, Gary W.en_US
dc.date.accessioned2006-04-07T18:03:14Z
dc.date.available2006-04-07T18:03:14Z
dc.date.issued1981-08-01en_US
dc.identifier.citationDonn, StevenM., Roloff, DietrichW., Goldstein, GaryW. (1981/08/01)."PREVENTION OF INTRAVENTRICULAR HAEMORRHAGE IN PRETERM INFANTS BY PHENOBARBITONE : A Controlled Trial." The Lancet 318(8240): 215-217. <http://hdl.handle.net/2027.42/24291>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T1B-49MDT59-8M/2/0b2c323d9ebd64c56e709c7a45e845a5en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/24291
dc.description.abstractSixty infants with birth-weights less than 1500 g and who were less than 6 h old were randomly assigned to a group given phenobarbitone or a control group. Intravenous phenobarbitone was given in doses sufficient to achieve anticonvulsant serum levels within 12-18 h. Maintenance therapy was continued for one week. Periventricular/intraventricular haemorrhage (IVH) occurred in 133% (4/30) of the phenobarbitone group and in 46.7% (14/30) of the control group. The occurrence of risk factors related to IVH was similar in the two groups. Phenobarbitone may reduce the incidence of IVH in small preterm infants.en_US
dc.format.extent391022 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titlePREVENTION OF INTRAVENTRICULAR HAEMORRHAGE IN PRETERM INFANTS BY PHENOBARBITONE : A Controlled Trialen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics, Sections of Newborn Services and Pediatric Neurology, and Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pediatrics, Sections of Newborn Services and Pediatric Neurology, and Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.contributor.affiliationumDepartment of Pediatrics, Sections of Newborn Services and Pediatric Neurology, and Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, U.S.A.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/24291/1/0000557.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/S0140-6736(81)90470-0en_US
dc.identifier.sourceThe Lanceten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000557.pdf
Size:
381.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.